Safety, tolerability and pharmacokinetics/pharmacodynamics of the adrenomedullin antibody adrecizumab in a first‐in‐human study and during experimental human endotoxaemia in healthy subjects

Christopher Geven, Peter Pickkers, Dirk van Lier et al.|British Journal of Clinical Pharmacology|2018

Cited by 44